Signalife, Inc.
4705 Laurel Canyon Bl. ~ Suite 203
Studio City, CA 91607
T 864.233.2300
F 864.233.2100
http://www.signalife.com
info@signalife.com


PRESS RELEASE
Tuesday February 19, 1:00 pm ET

Signalife & Athletes Foundation Complete Second Mobile Health Screening

LOS ANGELES, Feb. 19 /PRNewswire-FirstCall/ -- Athletes for Life Foundation (a District of Columbia Not for Profit Foundation) and Signalife (Amex: SGN - News) have just completed their second mobile health screening at the Arabian Horse Show in Scottsdale, Arizona -- the largest such event in the world, at its 35th anniversary.

Physicians and health care institutions from around the area donated their time to care for the patients, conducting dozens of screenings utilizing Signalife's award-winning Fidelity 100 ECG monitor. The screenings were conducted free of charge to the patients.

Willie Gault, the Foundation's founder, commented: "During the weekend, doctors reported that they had detected pathology in certain patients that was normally difficult or impossible to identify. Also, certain patients remarked to me that they were previously advised to undergo thousands of dollars of heart tests by their physicians -- but were given a clean bill of heart health at the event by the attending physicians. This is why I started the Foundation: To create some certainty in heart health, and to level the playing field from the perspective of cost and access for all persons. I would like to thank all those who donated their time to conduct these screenings and evaluations."

About Signalife
Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.

Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://www.Signalife.com. Clear Data. Trusted Results.

Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities and Exchange Commission.